Pfizer grows digital team with chief AI officer appointment
pharmaphorum
AUGUST 18, 2024
Pfizer has appointed Berta Rodriguez-Hervas to its digital leadership team, naming her chief artificial intelligence and analytics officer
Sun.Aug 18, 2024
110 
Long Time Passing: Where Have All the De Novo Decision Summaries Gone?
FDA Law Blog
AUGUST 18, 2024
By Véronique Li, Senior Medical Device Regulation Expert & Jeffrey N. Gibbs — In 1997, Congress wisely amended the Federal Food, Drug, and Cosmetic Act (FDCA) by adding Section 513(f)(2) to establish the De Novo process. The De Novo process provides a regulatory pathway to classify novel devices for which general controls alone or general and special controls provide reasonable assurance of safety and effectiveness for the intended use.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Telehealth Mindfulness-Based Interventions for Chronic Pain
JAMA Internal Medicine
AUGUST 18, 2024
This randomized clinical trial examines the effectiveness of group and self-paced scalable, telehealth mindfulness-based interventions for veterans with chronic pain compared to usual care.
Putting Patients First: The Shift Towards Patient-Centric Clinical Trials
ProRelix Research
AUGUST 18, 2024
Although time, speed, and operational constraints have long plagued the progress of clinical trials, another factor that remains important and has been gaining prime importance as the centre of clinical […] The post Putting Patients First: The Shift Towards Patient-Centric Clinical Trials appeared first on ProRelix Research.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Which pharmaceutical companies have the most SPCs in Spain?
Drug Patent Watch
AUGUST 18, 2024
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Spain.
New tentative approval for Alembic drug dabigatran etexilate mesylate
Drug Patent Watch
AUGUST 18, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Let's personalize your content